|
|
||||||||
Journal of Applied Physiology, Vol 80, Issue 1 351-356, Copyright © 1996 by American Physiological Society
ARTICLES |
T. Schmehl, J. Gebhart, H. Schutte, A. Scharmann and W. Seeger
Department of Internal Medicine, Justus-Liebig University, Giessen, Germany.
A photometric technique was developed for on-line measurement of aerosol deposition in isolated, ventilated, and perfused rabbit lungs. A jet nebulizer was used for aerosolization of saline (hygroscopic particles) and di(2-ethylhexyl) sebacate (nonhygroscopic particles). Aerosol concentration (laser photometer, constructed for measurements in rabbit lungs) and flow rate (commercial pneumotachograph) were continuously monitored at the inlet of the tracheal cannula. Computer-assisted data processing allowed the breath-by-breath calculation of inhaled and exhaled aerosol mass, thus providing the deposition fraction. With the use of hygroscopic particles, however, this approach was hampered by the humidity-induced particle growth in the airways, leading to an overestimation of the aerosol concentration in exhaled air. This effect was corrected by an algorithm using a "particle growth factor" derived breath by breath from the photometer signal. To test the reliability of this approach, saline particles carrying technetium-99m label were aerosolized into rabbit lungs with the use of various ventilator settings, and the aerosol deposition was assessed in parallel by photometry and by radioactivity detection over the lung and over a trap in the exhaled-air circuit. Superimposable curves of cumulative aerosol deposition, with changes in kinetics dependent on the ventilator mode, were obtained. For a given ventilator setting, absolute values of the deposition fraction were 0.32 +/- 0.04 (radiotracer quantification) and 0.36 +/- 0.04 (photometry; means +/- SD; n = 4). We conclude that the presented laser-photometric technique allows reliable on-line monitoring of the deposition of both nonhygroscopic and hygroscopic aerosol particles in ventilated lungs.
This article has been cited by other articles:
![]() |
H. H. Leuchte, T. Meis, M. El-Nounou, J. Michalek, and J. Behr Inhalation of endothelin receptor blockers in pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L772 - L777. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.T. Schermuly, H. Leuchte, H.A. Ghofrani, N. Weissmann, F. Rose, M. Kohstall, H. Olschewski, C. Schudt, F. Grimminger, W. Seeger, et al. Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure Eur. Respir. J., August 1, 2003; 22(2): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Schermuly, A. Schulz, H. A. Ghofrani, A. Meidow, F. Rose, A. Roehl, N. Weissmann, M. Hildebrand, J. Kurz, F. Grimminger, et al. Pharmacokinetics and Metabolism of Infused versus Inhaled Iloprost in Isolated Rabbit Lungs J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 741 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, H. Leuchte, F. Grimminger, W. Seeger, and D. Walmrath Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1361 - L1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. SCHERMULY, E. KRUPNIK, H. TENOR, C. SCHUDT, N. WEISSMANN, F. ROSE, F. GRIMMINGER, W. SEEGER, D. WALMRATH, and H. A. GHOFRANI Coaerosolization of Phosphodiesterase Inhibitors Markedly Enhances the Pulmonary Vasodilatory Response to Inhaled Iloprost in Experimental Pulmonary Hypertension . Maintenance of Lung Selectivity Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1694 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Schermuly, N. Weissmann, B. Enke, H. A. Ghofrani, W. G. Forssmann, F. Grimminger, W. Seeger, and D. Walmrath Urodilatin, a Natriuretic Peptide Stimulating Particulate Guanylate Cyclase, and the Phosphodiesterase 5 Inhibitor Dipyridamole Attenuate Experimental Pulmonary Hypertension . Synergism upon Coapplication Am. J. Respir. Cell Mol. Biol., August 1, 2001; 25(2): 219 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schutte, A. Lockinger, W. Seeger, and F. Grimminger Aerosolized PGE1, PGI2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion Eur. Respir. J., July 1, 2001; 18(1): 15 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verbanck, D. Schuermans, W. Vincken, and M. Paiva Saline aerosol bolus dispersion. I. The effect of acinar airway alteration J Appl Physiol, May 1, 2001; 90(5): 1754 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Schermuly, A. Roehl, N. Weissmann, H. A. Ghofrani, C. Schudt, H. Tenor, F. Grimminger, W. Seeger, and D. Walmrath Subthreshold Doses of Specific Phosphodiesterase Type 3 and 4 Inhibitors Enhance the Pulmonary Vasodilatory Response to Nebulized Prostacyclin with Improvement in Gas Exchange J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 512 - 520. [Abstract] [Full Text] |
||||
![]() |
R. T. SCHERMULY, A. GÜNTHER, N. WEISSMANN, H. A. GHOFRANI, W. SEEGER, F. GRIMMINGER, and D. WALMRATH Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (VA/Q) Mismatch in a Model of Acute Lung Injury Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 152 - 159. [Abstract] [Full Text] |
||||
![]() |
H. Schütte, F. Grimminger, J. Otterbein, R. Spriestersbach, K. Mayer, D. Walmrath, and W. Seeger Efficiency of Aerosolized Nitric Oxide Donor Drugs to Achieve Sustained Pulmonary Vasodilation J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 985 - 994. [Abstract] [Full Text] |
||||
![]() |
R. SCHERMULY, T. SCHMEHL, A. GÜNTHER, F. GRIMMINGER, W. SEEGER, and D. WALMRATH Ultrasonic Nebulization for Efficient Delivery of Surfactant in a Model of Acute Lung Injury . Impact on Gas Exchange Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 445 - 453. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |